HARVARD BIOSCIENCE, INC. Business Acquisition, Contingent Consideration, at Fair Value (Deprecated 2013-01-31)
HARVARD BIOSCIENCE, INC. (HBIO) had Business Acquisition, Contingent Consideration, at Fair Value (Deprecated 2013-01-31) of $20.00 thousand as of 2012-06-30, per its 10-Q filed 2012-08-09.
Discontinued › Notes › Business Combinations
us-gaap:BusinessAcquisitionContingentConsiderationAtFairValue · last filed 2012-08-09
- 2012-06-30: Business Acquisition, Contingent Consideration, at Fair Value (Deprecated 2013-01-31) $20.00K.
- 2011-06-30: Business Acquisition, Contingent Consideration, at Fair Value (Deprecated 2013-01-31) $0.00.
| Period end | Business Acquisition, Contingent Consideration, at Fair Value (Deprecated 2013-01-31) |
|---|---|
| 2012-06-30 | $20.00K 10-Q · filed 2012-08-09 |
| 2011-06-30 | $0.00 10-Q · filed 2012-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |